Phase 2
Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere’s Disease Outcomes
https://clinicaltrials.gov/ct2/show/NCT04218123?type=Intr&cond=Meniere+Disease&lupd_s=12%2F23%2F2019&lupd_d=14
Condition : Meniere Disease
Interventions : Drug: Venlafaxine; Drug: Placebo oral tablet
Sponsors : Medical University of South Carolina; American Hearing Research Foundation
Not yet recruiting
Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere’s Disease Outcomes
NCT04218123
Mon, 06 Jan 2020 12:00:00 EST
SPI-1005 for the Treatment of Patients With Meniere’s Disease [Completed]
https://clinicaltrials.gov/ct2/show/NCT03325790?type=Intr&cond=Meniere+Disease&lupd_s=06%2F04%2F2019&lupd_d=14
Condition : Meniere’s Disease
Interventions : Drug: 200mg SPI-1005 BID; Drug: 400mg SPI-1005 BID; Other: Placebo
Sponsor : Sound Pharmaceuticals, Incorporated
Completed
SPI-1005 for the Treatment of Patients With Meniere’s Disease
NCT03325790
Mon, 30 Oct 2017 12:00:00 EDT